http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2053397-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4e69a456f4fcac792f8f7d7b967b4b2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-916 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2053397-A1 |
| titleOfInvention | PPM1E proteins and nucleic acids as targets for neurodegenerative diseases |
| abstract | Use of n(i) a gene coding for protein phosphatase 1 E, and/or n(ii) a transcription product of the gene coding for protein phosphatase 1 E, and/or n(iii) a translation product of the gene coding for protein phosphatase 1 E, and/or n(iv) a fragment, or derivative, or variant of (i) to (iii). n in a method for identifying or for testing agents for the treatment or prevention of neurodegenerative diseases. |
| priorityDate | 2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 309.